| Literature DB >> 20840520 |
Gaoxing Luo1, Wenguang Cheng, Weifeng He, Xiaojuan Wang, Jiangling Tan, Mark Fitzgerald, Xianchang Li, Jun Wu.
Abstract
This study aimed to determine whether mesenchymal stem cells (MSCs) derived from umbilical cord blood (UCB) would promote cutaneous wound healing. MSCs from human UCB were isolated and identified. The characteristics of the isolated MSCs' growth and proliferation were assayed in vitro. The MSCs labeled with 5-bromodeoxyuridine (BrdU) were applied on fresh cutaneous mice wounds. The healing rates were surveyed. The distribution and the differentiation into keratinocytes of the labeled MSCs in the wound tissue were checked by immunohistochemistry staining. The isolated MSCs could grow and proliferate well in vitro. The isolated MSCs from UCB could be labeled by 5-bromodeoxyuridine successfully. The MSCs derived from UCB could enhance the healing of mice skin defect wounds, and it was found that the implanted MSCs could differentiate into keratinocyte in the wound tissue. It was demonstrated that MSCs from UCB can be isolated and proliferated successfully. The local administration of MSCs derived from UCB improves skin defect wound healing in mice.Entities:
Mesh：
Year: 2010 PMID： 20840520 DOI： 10.1111/j.1524-475X.2010.00616.x
Source DB: PubMed Journal: Wound Repair Regen ISSN： 1067-1927 Impact factor: 3.617